ICL Group Ltd.’s SEC filings document its reporting as a foreign private issuer with shares listed on the NYSE and TASE. Form 20-F and Form 6-K disclosures cover the company’s specialty minerals operations, segment performance, investor presentations, audited financial statements and risk factors related to commodity markets, exchange rates, mineral extraction permits and regional conditions in Israel.
Current reports also record dividend distributions, credit-rating updates, executive-management governance matters, registration-statement and Israeli shelf-prospectus incorporation references, and material agreements affecting the Dead Sea concession assets. These filings describe capital-return mechanics, tax withholding on distributions, board actions, and the company’s potash, phosphate, bromine, growing solutions and industrial product activities.
ICL Group Ltd. executive Mishor Miriam, EVP Global IT, reported existing derivative holdings in a Form 3. The filing shows stock options giving rights to acquire 464,902 Ordinary Shares at an exercise price of $9.39 per share, expiring on February 8, 2027; these options are fully vested and exercisable and are held by a Trustee in the reporting person's name.
A second option position covers 620,177 Ordinary Shares at an exercise price of $5.87 per share, expiring on April 4, 2029, vesting in three equal annual installments from the April 4, 2024 grant date. The Form 3 records these as direct beneficial holdings and does not reflect new purchases or sales, but rather the baseline option positions as of the reporting date.
ICL Group Ltd. executive Maya Grinfeld, SVP of Marketing & Communications, reported holding stock options over 189,846 Ordinary Shares. The options carry an exercise price of $7.33 per share, vest in three equal annual installments from the July 6, 2025 grant date, and expire on July 6, 2030. The options are held by a trustee in her name, reflecting a compensation-based right to buy, rather than a recent market trade.
ICL Group Ltd. Deputy Chief Executive Officer Geva Harel Lilach reported existing holdings of stock options to buy Ordinary Shares. The Form 3 lists three option grants with exercise prices in U.S. dollars, converted from New Israeli Shekels using Bank of Israel exchange rates.
One option grant covers 649,180 underlying shares at an exercise price of $9.39 per share, is fully vested and exercisable, and expires on February 8, 2027. Additional grants cover 984,095 underlying shares at $5.87 per share expiring April 4, 2029, and 416,667 underlying shares at $5.91 per share expiring December 7, 2030, each vesting in three equal annual installments from their respective grant dates. The options are held by a Trustee in the name of the reporting person.
ICL Group Ltd. executive Fahima Ilana, EVP and Chief People Officer, filed an initial statement of beneficial ownership showing significant stock option holdings in ICL Group.
She holds stock options over 649,180 ordinary shares with a $9.39 exercise price expiring on February 8, 2027, and options over 984,095 ordinary shares with a $5.87 exercise price expiring on April 4, 2029. According to the notes, one grant of stock options is fully vested and exercisable, while another grant vests in three equal annual installments from the April 4, 2024 grant date, with the options held by a trustee in her name.
ICL Group Ltd. President & CEO Elad Aharonson reported existing holdings of stock options to buy ICL ordinary shares. These options cover 306,748 underlying shares at an exercise price of $6.39 per share expiring on June 30, 2026, 737,705 underlying shares at $9.39 expiring on February 8, 2027, 1,118,290 underlying shares at $5.87 expiring on April 4, 2029, and 2,308,963 underlying shares at $6.78 expiring on March 13, 2030. Footnotes state that some options are fully vested and exercisable, while others vest in three annual installments from April 4, 2024 and March 13, 2025, including specified vesting percentages.
ICL Group Ltd. Chief Financial Officer Lahav Aviram reported his initial holdings of stock options linked to the company’s ordinary shares. He holds stock options over 784,918 underlying ordinary shares at an exercise price of $9.39 per share, expiring on February 8, 2027. He also holds stock options over 1,189,861 underlying ordinary shares at an exercise price of $5.87 per share, expiring on April 4, 2029. According to the notes, one option grant is fully vested and exercisable, while the other vests in three equal annual installments from the April 4, 2024 grant date, and the options are held by a trustee in his name.
ICL Group Ltd. executive Desikan Anantha reported existing stock option holdings in a Form 3. He holds stock options over 545,365 Ordinary Shares at an exercise price of $9.93 per share, fully vested and exercisable, expiring on February 8, 2027.
He also holds stock options over 940,285 Ordinary Shares at an exercise price of $6.03 per share, vesting in three equal annual installments from the April 4, 2024 grant date and expiring on April 4, 2029. The options are held by a Trustee in his name.
ICL Group Ltd. executive Meshulam Amir, SVP Global Internal Audit, reported his initial ownership of stock options in a Form 3 filing. He holds fully vested options over 206,557 Ordinary Shares with a $9.39 exercise price, expiring on February 8, 2027. He also holds options over 275,547 Ordinary Shares at a $5.87 exercise price, expiring on April 4, 2029, which vest in three equal annual installments starting from April 4, 2025. The options are held by a trustee in his name, and this filing reflects holdings rather than new purchases or sales.
ICL Group Ltd. filed an initial ownership report for Michal Silverberg, identifying her as a director of the company. The filing lists no common stock or derivative transactions, with buy, sell, acquire, dispose, exercise, gift, tax withholding, and restructuring share counts all reported as zero.
ICL Group Ltd. executive Barkai Ilan filed an initial ownership report showing existing equity positions. He holds stock options over 472,779 Ordinary Shares with an exercise price of $7.02 per share, expiring on May 1, 2030, vesting in three equal annual installments from May 1, 2025, and held by a Trustee. He also directly owns 463 Ordinary Shares.